Penicillium metabolic engineering services offer specialized solutions for optimizing the metabolic pathways of Penicillium species to enhance the production of valuable biochemicals, pharmaceuticals, enzymes, and other industrially relevant products. Our comprehensive services provide support from initial project design to final strain optimization, ensuring precise and efficient metabolic modifications tailored to your specific research and biotechnological needs.
Integration of the calbistrin cluster from P. decumbens into 4xKO-B and verifcation of production. (C Pohl, et al.,2020)
Penicillium species, including Penicillium chrysogenum and Penicillium roqueforti, are widely used in biotechnology for their ability to produce antibiotics, enzymes, and secondary metabolites. Our metabolic engineering services leverage advanced genetic engineering techniques, such as CRISPR/Cas9, homologous recombination, and synthetic biology approaches, to optimize the metabolic pathways of Penicillium for improved production of target compounds.
The process of Penicillium metabolic engineering involves several critical and interrelated steps:
For more information about our Penicillium Metabolic Engineering Services or to discuss your specific needs, please contact us. Our team of experts is available to provide guidance and support for your research and biotechnological projects, ensuring you achieve your scientific and industrial goals.
The following table provides an overview of various case studies in Penicillium metabolic engineering and the solutions we offer to support your research and biotechnological endeavors:
Case Study | Description | Solutions We Offer |
---|---|---|
Antibiotic Production Enhancement | Engineering Penicillium strains to increase the yield of antibiotics such as penicillin. | Pathway design, genetic modification, strain optimization, and scale-up. |
Statin Production Optimization | Modifying metabolic pathways to enhance the production of statins. | CRISPR/Cas9 gene editing, pathway optimization, and production scaling. |
Organic Acid Production | Developing strains for the efficient production of organic acids for industrial use. | Metabolic pathway reconstruction, strain engineering, and yield optimization. |
Industrial Enzyme Production | Engineering Penicillium to produce high levels of industrial enzymes. | Pathway design, strain development, and production optimization. |
Biochemical Synthesis | Engineering Penicillium to produce solvents and other industrial biochemicals. | Synthetic biology, pathway integration, and functional assays. |
Synthetic Pathway Construction | Constructing synthetic pathways in Penicillium for the production of novel biochemicals. | Synthetic biology, pathway integration, and functional assays. |
Penicillium chrysogenum was successfully engineered to produce a novel carbamoylated cephalosporin that can be used as a synthon for semi-synthetic cephalosporins. To this end, genes for Acremonium chrysogenum expandase/hydroxylase and Streptomyces clavuligerus carbamoyltransferase were expressed in a penicillinG high-producing strain of P. chrysogenum. Growth of the engineered strain in the presence of adipic acid resulted in production of adipoyl-7-amino-3-carbamoyloxymethyl3-cephem-4-carboxylic acid (ad7-ACCCA) and of several adipoylated pathway intermediates. A combinatorial chemostat-based transcriptome study, in which the ad7-ACCCA-producing strain and a strain lacking key genes in b-lactam synthesis were grown in the presence and absence of adipic acid, enabled the dissection of transcriptional responses to adipic acid per se and to ad7-ACCCA production. Transcriptome analysis revealed that adipate catabolism in P. chrysogenum occurs via b-oxidation and enabled the identification of putative genes for enzymes involved in mitochondrial and peroxisomal b-oxidation pathways. Several of the genes that showed a specifically altered transcript level in ad7- ACCCA-producing cultures were previously implicated in oxidative stress responses
ad7-ACCCA production in shake flasks(DM Harris, et al.,2009)
ad7-ACCCA production in shake flasks. (A) NMR spectrum of ad7ACCCA-producing DS17690 P. chrysogenum transformants. (B) Relative stability of ad7-ACCCA at various conditions. The pH of ad7-ACCCA-containing filtrates was adjusted with 4 N HCl or 4 N KOH to either pH 4 or 13. The samples were then incubated for 8 h at 4, 25 and 80 1C and subsequently analysed by NMR. (C) Relative concentration distribution of ad7ADACCCA and intermediates in shake-flask experiments after 7 days of cultures. The experiment was performed in triplicate and the standard error did not exceed 10%.
A: Penicillium metabolic engineering involves the genetic modification of Penicillium strains to optimize their metabolic pathways for the production of target compounds. This can include introducing, deleting, or modifying specific genes to redirect metabolic fluxes and increase the yield of desired products.
A: Penicillium metabolic engineering is performed through a series of steps including project consultation, pathway analysis and design, vector design and construction, fungal transformation, selection and screening, strain optimization, characterization and validation, scale-up and production, and reporting. Each step ensures precise and efficient metabolic modifications.
A: Applications include antibiotic production, pharmaceutical production, industrial enzyme production, biochemicals production, agricultural biotechnology, and synthetic biology. Engineered Penicillium strains are used to produce valuable bioproducts and address various industrial and environmental challenges.
A: Key steps include project consultation, pathway analysis and design, vector design and construction, fungal transformation, selection and screening, strain optimization, characterization and validation, scale-up and production, and reporting. These steps ensure comprehensive and accurate development of engineered Penicillium strains.
A: Penicillium metabolic engineering is important for advancing research, developing new bioproducts, optimizing industrial processes, and addressing environmental challenges. Engineered Penicillium strains provide valuable tools for enhancing production yields and creating novel compounds.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.